Chagas disease in Uruguay: the first finding by Rodolfo Tálice
DOI:
https://doi.org/10.35954/SM2013.32.1.9Keywords:
Chagas disease; Trypanosomiasis; South American trypanosomiasis.Abstract
The year 2009 marked the first centenary of the discovery of Chagas disease. Uruguay is the first South American country free of the vinchuca, a hematophagous insect that transmits Chagas disease, a parasitosis endemic in the region caused by Trypanosoma cruzi. Since 1997, no transmission of the disease by vinchuca or transfusions has been recorded in Uruguay, in addition to the elimination, officially recognized in 2012 by the health authorities, of the insect vector, Triatoma infestans (vinchuca) throughout Uruguay. The last outbreaks were located in the departments of Tacuarembó, Rivera and Colonia. At the meeting of the Subregional Chagas Disease Initiatives organization held at its headquarters in Buenos Aires, Uruguay received international validation and recognition for being the first country in the region to eliminate the vinchuca bug. Uruguay's representatives received the distinction from the Pan American Health Organization (PAHO) on August 29, 2012. At the summit of technicians from all South American countries, the Minister of Health of Argentina and the PAHO representative in Argentina presented the international recognition to Uruguayan doctors Ciro Ferreira (president of the National Zoonosis Commission) and Julio Sayes (veterinarian and director of the Commission) for the work carried out to eradicate the vinchuca bug. Such precious merit for our country goes back to the compatriot doctor Rodolfo Tálice, who in 1939 identified and described the first case of Chagas Disease or American Trypanosomiasis in Uruguay from the blood of a girl from the interior of the country.
Downloads
Metrics
References
(1) Mañé Garzón F. Rodolfo V Tálice (1899-1999): Genio y figura. Rev Med Uruguay 1999; 15(2): 85-93.
(2) Conti Díaz I. A propósito del centenario del descubrimiento de la enfermedad de Chagas. Rev Med Uruguay 2010; 26(2): 108-116.
(3) Tálice R. Cuentos, confidencias, confesiones. Prólogo de Francisco Espínola. Montevideo : Arca Editorial, 1969 (Colección sésamo), 189 p.
(4) Brumpt E. Recherches parasitologiques en Uruguay. An Fac Med (Montevideo)1928; 13: 83-100.
(5) Enfermedad de Chagas. Disponible en: http:// es.wikipedia.org/wiki/Enfermedad_de_Chagas#cite [Consulta 05/10/2013]
(6) Enfermedad de Chagas. Descubrimiento de la enfermedad. Disponible en: http://es.wikipedia.org/wiki/ Enfermedad_de_Chagas [Consulta 05/10/2013]
(7) Salgado JA, Garcez PN, de Oliveira CA, Galizzi J. Revisão clínica atual do primeiro caso humano descrito da doença de Chagas. Rev Inst Med Trop São Paulo 1962: 4(5): 330-337.
(8) Chagas C. Nova tripanozomiase humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1909; 1(2): 159-218.
(9) Gaminara A. Enfermedad de Chagas en el Uruguay. Estudio experimental sobre Schizotripanum Cruzi. An Fac Med (Montevideo) 1923; 8: 311.
(10) Gaminara, A. Infección natural de Triatoma rubrovaria por Schizotrypanum cruzi en el Uruguay. Bol Cons Nac Hig (Montevideo)1923; 18: 571-5.
(11) Enfermedad de Chagas. Darwin y la enfermedad de Chagas. Disponible en: http://es.wikipedia.org/wiki/ Enfermedad_de_Chagas [Consulta 05/10/2013]
(12) De Haro Arteaga I. Algunos hechos históricos relacionados con la enfermedad de Chagas. Rev Mex Patol Clin 2003; 50:109-112.
(13) Adler D. Darwin’s Illness. Isr J Med Sci 1989; 25(4): 218-21.
(14) Rassi Jr. A, Rassi A, Marin-Neto JA. Chagas disease. The Lancet 2010; 375 (9723): 1388-1402.
(15) Bean WB. The illness of Charles Darwin. Am J Med 1978; 65(4): 572-4.
(16) Hudson GH. La tierra purpúrea. Buenos Aires : Zurbarán Ediciones, 1996, pág. 36.
(17) OMS. Comité de Expertos. Control de Enfermedad de Chagas. Ginebra, 1991. Serie de Informes Técnicos Nº 181.
(18) Brumpt E. Recherches parasitologiques en Uruguay. An Fac Med (Montevideo) 1928; 13: 83-100.
(19) Tálice R, de Medina F, Rial B. Primer caso de Enfermedad de Chagas en el Uruguay. An Fac Med (Montevideo) 1937; 22: 235-52.
(20) Mazza S. Casos agudos benignos de Enfermedad de Chagas comprobados en la provincia de Jujuy. Misión de Estudios de Patología Regional Argentina (MEPRA) 1934; 17: 3-11.
(21) Tálice R. Memorias de un siglo. Montevideo : S.A Publicaciones y Ediciones, 1994.
(22) Tálice R, de Medina F, Rial B. Primer caso de Enfermedad de Chagas en el Uruguay. An Fac Med (Montevideo) 1937; 22: 253-66.
(23) Tálice R, Miranda N, Costa R. Primer caso en el país de forma aguda mortal de enfermedad de Chagas (41º caso uruguayo) observado en el departamento de Rivera (Minas de Corrales). An Fac Med (Montevideo) 1939; 24: 69-78.
(24) Tálice R, Costa R, Rial B, Osimani J. Los 100 primeros casos agudos confirmados de enfermedad de Chagas (Trypanosomiasis Americana) en el Uruguay. Estudio epidemiológico, clínico y parasitológico. Montevideo : Monteverde, 1940, 340 p.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
